OCLN and metabolic syndrome: Oral administration of Akkermansia can increase the number of goblet cells, restore the mucus thickness of the inner layer, and up-regulated the expression of tight-junction proteins including occludin, claudin, and ZO-1, in the gut of mice with metabolic syndrome (Everard et al., 2013; Grander et al., 2018).